"Biotechs Use Gene Silencing for Extended Obesity Drug Efficacy"
TL;DR
Biotech companies are exploring RNA interference to develop longer-lasting obesity treatments, potentially shifting from weekly hormone-targeting drugs like Wegovy to less frequent, gene-targeted therapies.
Topics:healthhealth-and-biotechnology#biotech-companies#gene-silencing#health-and-biotechnology#obesity#rna-interference#weight-loss-drugs
Want the full story? Read the original reporting
Read on STAT